Clinical trials: Mid-Portion Achilles Tendinopathy
Achilles Tendinopathy
A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy
The purpose of this study is to measure local and systemic safety and tolerability as well as improvement of Achilles tendon mechanical properties after a single peritendon injection of NGI226 MP in comparison to placebo MP in…
- Trial name
- NCT05592990
- Testing
- NGI226
- Where
- 7 sites in United States, France and 1 more
- Volunteers
- 45 people
- Sponsor
- Novartis Pharmaceuticals